MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

11.74 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 11.74
Bid (Size) 11.51 (200)
Ask (Size) 11.76 (100)
Prev. Close 11.74
Today's Range 11.74 - 11.74
52wk Range 9.130 - 20.12
Shares Outstanding 148,077,055
Dividend Yield 3.00%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Billion-Dollar Gamble: Why Alta Fundamental Advisers is Doubling Down on a Battered Chemours
In the high-stakes world of hedge fund management, few strategies are as nerve-wracking—or potentially lucrative—as the contrarian "deep value" play. This month, the spotlight has fallen on Alta... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Calumet Exit: What a $7 Million Sell-Off Signals for a Struggling Energy Stock ↗
Calumet just posted eye-catching profits, but one fund still headed for the exits. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-29.7%
-29.7%
1 Month
+2.1%
+2.1%
3 Month
-28.8%
-28.8%
6 Month
+5.3%
+5.3%
1 Year
-33.1%
-33.1%

More News

Read More
News headline image
This Chemicals Stock Is Down 32% but Just Became a Top 5 Holding After One Fund's $13 Million Bet ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For November 6, 2025 ↗
Via Benzinga
News headline image
Where Chemours Stands With Analysts ↗
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Chemours Stock ↗
Via Benzinga
News headline image
Amid a 13% Stock Slide, a Fund Scales Back Its Lucky Strike Exposure by $9 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Chemours Appoints Michael Foley as President of Titanium Technologies; Announces Departure of Damián Gumpel
From The Chemours Company
Via Business Wire
News headline image
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
XRP ETFs Ignite Market with Near-$1 Billion Debut, Signaling Robust Institutional Appetite
Via BreakingCrypto
Topics ETFs Economy Regulatory Compliance
News headline image
Fund Adds $7.2 Million Powell Stake as the Electrical Supplier Posts Record $181 Million Profit ↗
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
This Fund Just Took a $5.5 Million Stake in a Turnaround Stock Up 143% This Past Year ↗
Via The Motley Fool
News headline image
Top 3 Materials Stocks That Are Preparing To Pump In Q4 ↗
Via Benzinga
News headline image
Chemours (NYSE:CC) Q3 2025 Earnings Miss Estimates, Stock Falls on Weak Guidance ↗
Via Chartmill
Topics Earnings
News headline image
The Chemours Company Reports Third Quarter 2025 Results
From The Chemours Company
Via Business Wire
News headline image
Chemours Announces Fourth Quarter Dividend
From The Chemours Company
Via Business Wire
News headline image
Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call
From The Chemours Company
Via Business Wire
News headline image
Investment Company Luminus Loaded Up on This Leading Industrials Stock. Is It a Buy? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Luminus Dumps About 43,000 Quaker Chemical Shares Worth $5.6 Million ↗
Via The Motley Fool
Topics Regulatory Compliance World Trade
News headline image
Luminus Trims Its Hefty Chemours Position ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending ↗
Via MarketBeat
Topics Economy Stocks World Trade
News headline image
THE CHEMOURS COMPANY INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of The Chemours Company - CC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report ↗
Via Benzinga
News headline image
Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director
From The Chemours Company
Via Business Wire
News headline image
DuPont Divests Aramids Business In $1.8 Billion Deal To Sharpen Portfolio ↗
Via Benzinga

Frequently Asked Questions

Is Chemours Company (The) Common Stock publicly traded?
Yes, Chemours Company (The) Common Stock is publicly traded.
What exchange does Chemours Company (The) Common Stock trade on?
Chemours Company (The) Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Chemours Company (The) Common Stock?
The ticker symbol for Chemours Company (The) Common Stock is CC on the New York Stock Exchange
What is the current price of Chemours Company (The) Common Stock?
The current price of Chemours Company (The) Common Stock is 11.74
When was Chemours Company (The) Common Stock last traded?
The last trade of Chemours Company (The) Common Stock was at 12/23/25 07:00 PM ET
What is the market capitalization of Chemours Company (The) Common Stock?
The market capitalization of Chemours Company (The) Common Stock is 1.74B
How many shares of Chemours Company (The) Common Stock are outstanding?
Chemours Company (The) Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story